Fig. 6. No side effects by OVA/CHP nanogel vaccine and the combination therapy with anti-PD-1 antibody. E.G7-OVA tumor-bearing mice (n = 4) were treated with vaccines and anti-PD-1 antibody, and measured for their spleen weight (A), lung water content (B), and serum AST level (C) as side effects. (D and E) Mice were monitored for their body weight during treatment (D) and tumor weight (E). Data are shown as means ± SEM.
